Brain Shrinkage in Anti–β-Amyloid Alzheimer Trials-Reference-Cited by-同舟云学术

Brain Shrinkage in Anti–β-Amyloid Alzheimer Trials

Published:2023-05-16 Issue:20 Volume:100 Page:941-942
ISSN:0028-3878
Container-title:Neurology
language:en
Short-container-title:Neurology

Author:

Barkhof Frederik¹,Knopman David S.¹

Affiliation:

1. From the Department of Radiology and Nuclear Medicine (F.B.), Amsterdam University Medical Center, VU Medical Center, Amsterdam, Netherlands; Queen Square Institute of Neurology and Centre for Medical Image Computing (F.B.), University College London, UK; Department of Neurology (D.S.K.) and Mayo Clinic Alzheimer Research Center, Mayo Clinic, Rochester MN.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Neurology (clinical)

Link

https://www.neurology.org/doi/pdfdirect/10.1212/WNL.0000000000207268

Reference10 articles.

1. Accelerated Brain Volume Loss Caused by Anti–β-Amyloid Drugs

2. Whole-Brain Atrophy Rate and Cognitive Decline: Longitudinal MR Study of Memory Clinic Patients

3. Donanemab in Early Alzheimer’s Disease

4. Lecanemab in Early Alzheimer’s Disease

5. Bateman RJ. Clarity AD: A phase 3 placebo-controlled double-blind parallel-group 18-month study evaluating lecanemab in early Alzheimer's disease: imaging plasma and CSF biomarkers assessments from Clarity AD. Paper presented at: Clinical Trials In Alzheimer's Disease Conference; November 2022; San Francisco CA.

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neuroimaging to Facilitate Clinical Trials in Huntington’s Disease: Current Opinion from the EHDN Imaging Working Group;Journal of Huntington's Disease;2024-07-02

2. Conveying Risks of Harm in Alzheimer Disease by Amyloid Lowering;JAMA;2024-06-18

3. New and emerging drug therapies for Alzheimer disease;Australian Prescriber;2024-06-18

4. Scanning ultrasound-mediated memory and functional improvements do not require amyloid-β reduction;Molecular Psychiatry;2024-03-18

5. Reply to the Letter to the Editor: Response to Concerns Raised on MRI Surveillance and Clinical Implications of ARIA in Disease Modifying Treatment;The Journal of Prevention of Alzheimer's Disease;2024